SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-018392
Filing Date
2024-02-22
Accepted
2024-02-22 06:30:30
Documents
60
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nerv-20231231.htm   iXBRL 10-K 2114696
2 EX-23.1 nerv-ex23_1.htm EX-23.1 3179
3 EX-31.1 nerv-ex31_1.htm EX-31.1 12932
4 EX-31.2 nerv-ex31_2.htm EX-31.2 12651
5 EX-32.1 nerv-ex32_1.htm EX-32.1 9178
6 EX-97 nerv-ex97.htm EX-97 48201
  Complete submission text file 0000950170-24-018392.txt   7010231

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nerv-20231231.xsd EX-101.SCH 1035229
62 EXTRACTED XBRL INSTANCE DOCUMENT nerv-20231231_htm.xml XML 888186
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36517 | Film No.: 24662198
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)